Cargando…
Patient considerations in the use of tapentadol for moderate to severe pain
Poorly controlled acute and chronic pain can increase morbidity, impair quality of life and prolong disability. Over 80 percent of post surgical patients report moderate to severe uncontrolled postoperative pain. Over-reliance on potent opioid agonists can lead to several opioid related side effects...
Autores principales: | Vadivelu, Nalini, Huang, Yili, Mirante, Brian, Jacoby, Michael, Braveman, Ferne R, Hines, Roberta L, Sinatra, Raymond |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3704302/ https://www.ncbi.nlm.nih.gov/pubmed/23861601 http://dx.doi.org/10.2147/DHPS.S28829 |
Ejemplares similares
-
Tapentadol extended-release for treatment of chronic pain: a review
por: Vadivelu, Nalini, et al.
Publicado: (2011) -
Tapentadol extended release in the management of peripheral diabetic neuropathic pain
por: Vadivelu, Nalini, et al.
Publicado: (2015) -
Lasting Prolonged-Release Tapentadol for Moderate/Severe Non-Cancer Musculoskeletal Chronic Pain
por: Samolsky Dekel, Boaz G., et al.
Publicado: (2015) -
Tapentadol for the Treatment of Moderate-to-Severe Acute Pain in Children Under the Age of Two Years
por: Eissa, Ayman, et al.
Publicado: (2021) -
Management of chronic pain in the elderly: focus on transdermal buprenorphine
por: Vadivelu, Nalini, et al.
Publicado: (2008)